Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo
Status:
Unknown status
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the effectiveness of Tacrolimus 0.03% ointment monotherapy in
patients with vitiligo. Patients will be treated for 6 months and followed for 3 months after
treatment. All types of vitiligo will be included.